Search details
1.
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
N Engl J Med
; 384(1): 31-41, 2021 01 07.
Article
in English
| MEDLINE | ID: mdl-33200890
2.
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.
Eur Heart J
; 43(31): 2946-2957, 2022 08 14.
Article
in English
| MEDLINE | ID: mdl-34528670
3.
Recurrent Pericarditis: a Stubborn Opponent Meets New Treatments in 2022.
Curr Cardiol Rep
; 24(8): 915-923, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35612721
4.
SERCA2a-phospholamban interaction monitored by an interposed circularly permutated green fluorescent protein.
Am J Physiol Heart Circ Physiol
; 320(6): H2188-H2200, 2021 06 01.
Article
in English
| MEDLINE | ID: mdl-33861144
5.
Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept.
BMC Cardiovasc Disord
; 21(1): 201, 2021 04 21.
Article
in English
| MEDLINE | ID: mdl-33882846
6.
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1Ć trap, in patients with recurrent pericarditis.
Am Heart J
; 228: 81-90, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32866928
7.
Safety and Feasibility of a Nocturnal Heart Rate Elevation-Exploration of a Novel Treatment Concept.
J Card Fail
; 25(1): 67-71, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30026129
8.
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
N Engl J Med
; 373(24): 2314-24, 2015 Dec 10.
Article
in English
| MEDLINE | ID: mdl-26549714
9.
Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept.
Heart Fail Rev
; 23(4): 499-506, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29098508
10.
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.
JAMA
; 320(17): 1764-1773, 2018 11 06.
Article
in English
| MEDLINE | ID: mdl-30398602
11.
A Targeted Treatment Opportunity for HFpEF: Taking Advantage of Diastolic Tone.
Circulation
; 144(16): 1269-1271, 2021 10 19.
Article
in English
| MEDLINE | ID: mdl-34662157
12.
Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
Circulation
; 131(14): 1247-59, 2015 Apr 07.
Article
in English
| MEDLINE | ID: mdl-25637629
13.
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.
Circulation
; 131(20): 1763-71, 2015 May 19.
Article
in English
| MEDLINE | ID: mdl-25986447
14.
Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept.
Am J Physiol Heart Circ Physiol
; 311(4): H1031-H1039, 2016 10 01.
Article
in English
| MEDLINE | ID: mdl-27591220
15.
Ultrafiltration in decompensated heart failure with cardiorenal syndrome.
N Engl J Med
; 367(24): 2296-304, 2012 Dec 13.
Article
in English
| MEDLINE | ID: mdl-23131078
16.
Beta-Blocker Cessation in Stable Outpatients With Heart Failure With a Preserved Ejection Fraction.
J Card Fail
; 26(3): 281-282, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31479746
17.
Evaluation and Treatment of Pericarditis: A Systematic Review.
JAMA
; 314(14): 1498-506, 2015 Oct 13.
Article
in English
| MEDLINE | ID: mdl-26461998
18.
Diuretic strategies in patients with acute decompensated heart failure.
N Engl J Med
; 364(9): 797-805, 2011 Mar 03.
Article
in English
| MEDLINE | ID: mdl-21366472
19.
Cardiac titin and heart disease.
J Cardiovasc Pharmacol
; 63(3): 207-12, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24072177
20.
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept.
J Am Heart Assoc
; 13(6): e032516, 2024 Mar 19.
Article
in English
| MEDLINE | ID: mdl-38471825